VCM
VANI icon

Versant Capital Management’s Vivani Medical VANI Stock Holding History

Versant Capital Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 1546
2016
Q4 		$0 Hold
2
– – ﹤0.01% 1540
2016
Q3 		$0 Buy
+2
New +$177 ﹤0.01% 1500

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Versant Capital Management's VANI Position: Q1 2017 in Review

Versant Capital Management sold out of Vivani Medical (VANI) in Q1 2017, closing a stake of 2 shares.

Versant Capital Management first reported a position in VANI in Q3 2016 and held it in 2 quarters. The position peaked at $0 in Q4 2016. 58 funds tracked by Wall St. Rank hold VANI as of Q1 2017.

  • Versant Capital Management reported no remaining Vivani Medical position as of Q1 2017 after selling out during the quarter.
  • Versant Capital Management sold 2 Vivani Medical shares in Q1 2017.
  • Versant Capital Management first reported a position in Vivani Medical in Q3 2016 and held it in 2 quarters.
  • Versant Capital Management's Vivani Medical position peaked at $0 in Q4 2016.
  • 58 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2017.

Based on Versant Capital Management's 13F filing for Q1 2017, filed 23 Apr 2018.